M
CL icon

Mirova’s Colgate-Palmolive CL Stock Holding History

Mirova’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.79M Sell
114,813
-23,185
-17% -$2.07M 0.4% 83
2025
Q4 		$10.9M Sell
137,998
-4,189
-3% -$328K 1.57% 17
2025
Q3 		$11.4M Buy
142,187
+11,168
+9% +$953K 1.61% 16
2025
Q2 		$11.9M Buy
131,019
+58,759
+81% +$5.36M 1.68% 14
2025
Q1 		$6.77M Sell
72,260
-21,087
-23% -$1.89M 1.22% 18
2024
Q4 		$8.49M Buy
93,347
+6,693
+8% +$639K 1.46% 14
2024
Q3 		$9M Sell
86,654
-11,692
-12% -$1.19M 1.55% 13
2024
Q2 		$9.54M Buy
98,346
+3,118
+3% +$288K 1.74% 11
2024
Q1 		$8.58M Buy
95,228
+39,636
+71% +$3.36M 1.52% 12
2023
Q4 		$4.43M Sell
55,592
-91
-0.2% -$6.84K 0.91% 24
2023
Q3 		$3.96M Sell
55,683
-7,771
-12% -$581K 0.8% 31
2023
Q2 		$4.89M Sell
63,454
-6,441
-9% -$499K 0.86% 23
2023
Q1 		$5.25M Sell
69,895
-5,359
-7% -$398K 0.76% 23
2022
Q4 		$5.93M Buy
75,254
+14,100
+23% +$1.06M 0.93% 13
2022
Q3 		$4.3M Sell
61,154
-12,458
-17% -$977K 0.72% 19
2022
Q2 		$5.9M Buy
73,612
+13,908
+23% +$1.09M 0.84% 19
2022
Q1 		$4.53M Buy
59,704
+165
+0.3% +$13.1K 0.61% 24
2021
Q4 		$5.08M Buy
59,539
+17,392
+41% +$1.36M 0.61% 19
2021
Q3 		$3.19M Buy
42,147
+1,257
+3% +$99.8K 0.41% 32
2021
Q2 		$3.33M Buy
40,890
+846
+2% +$69.2K 0.4% 34
2021
Q1 		$3.16M Buy
40,044
+12,287
+44% +$963K 0.38% 31
2020
Q4 		$2.37M Buy
27,757
+7,488
+37% +$619K 0.31% 30
2020
Q3 		$1.56M Buy
20,269
+5,102
+34% +$389K 0.25% 35
2020
Q2 		$1.11M Buy
15,167
+3,353
+28% +$238K 0.26% 37
2020
Q1 		$784K Buy
11,814
+5,764
+95% +$407K 0.3% 33
2019
Q4 		$416K Buy
6,050
+4,039
+201% +$275K 0.14% 43
2019
Q3 		$148K Buy
2,011
+106
+6% +$7.69K 0.02% 80
2019
Q2 		$137K Buy
1,905
+1,072
+129% +$76.1K 0.01% 78
2019
Q1 		$57K Buy
+833
New +$53.8K 0.03% 85

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Mirova's CL Position: Q1 2026 in Review

Mirova reduced its Colgate-Palmolive (CL) stake by 17% in Q1 2026, selling an estimated $2.07M and leaving 114,813 shares worth $9.79M. The position accounts for 0.4% of the portfolio, ranked #83.

Mirova first reported a position in CL in Q1 2019 and has held it in 29 quarters since. The position peaked at $11.9M in Q2 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Mirova held 114,813 shares of Colgate-Palmolive worth $9.79M as of Q1 2026.
  • Mirova sold 23,185 Colgate-Palmolive shares in Q1 2026, an estimated $2.07M.
  • Colgate-Palmolive made up 0.4% of Mirova's portfolio in Q1 2026, its #83 holding.
  • Mirova first reported a position in Colgate-Palmolive in Q1 2019 and has held it in 29 quarters since.
  • Mirova's Colgate-Palmolive position peaked at $11.9M in Q2 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Mirova's 13F filing for Q1 2026, filed 14 May 2026.